当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Chemical & Biomedical Imaging杂志
Chemical & Biomedical Imaging
基本信息
期刊名称 Chemical & Biomedical Imaging
期刊ISSN 2832-3637
期刊官方网站 https://pubs.acs.org/journal/cbihbp
是否OA
出版商 American Chemical Society (ACS)
出版周期 Monthly
文章处理费 登录后查看
始发年份 2023
年文章数
影响因子   scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位
补充信息
自引率
H-index
SCI收录状况
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC)
投稿指南
期刊投稿网址
收稿范围

Chemical & Biomedical Imaging(《化学与生物医学影像》)是一本同行评审的开放获取期刊,致力于发表有关化学和生物医学成像各个方面的前沿研究论文。这个跨学科领域位于化学,物理,生物学,材料,工程和医学的交叉点。该期刊旨在汇集来自这些学科的研究人员,以解决基础研究和应用的前沿挑战。


期刊欢迎以下论文:

分子和生物医学成像的创新

在单分子、单粒子或单细胞尺度上突破化学、空间和时间分辨率的极限

用于生物医学应用的新型化学探针和方法


期刊收录研究方向:

过程和反应的成像、纳米级、微尺度和中尺度材料的成像、生物相互作用和界面成像、单分子和细胞成像、全器官和全身成像、分子成像探针和造影剂、生物发光、化学发光和电化学发光成像、纳米光子学和成像、用于新成像模式的化学工具、化学和成像技术在诊断和治疗中的应用、影像引导药物输送、人工智能和机器学习辅助成像

收录体裁
Articles
Letters
Technical Notes
Reviews
Perspectives
Viewpoints
Editorials
投稿指南
投稿模板
参考文献格式
编辑信息

Editor-in-Chief

Zijian Guo

  • Zijian Guo

  • Professor, School of Chemistry and Chemical Engineering

  • Nanjing University

  • 163 Xianlin Rd, Nanjing, Jiangsu, P. R. China

  • Phone: 86-25-89689006

  • Email: eic@cbmi.acs.org

Selected Honors and Accolades

  • Academician of Chinese Academy of Sciences

  • Outstanding Achievement Award of 2020 Asian Biological Inorganic Chemistry (AsBIC)

  • Luigi Sacconi Medal (Italian Chemical Society)

  • The First Prize of the Ministry of Education of Natural Science in China

  • Changjiang Professorship

Current Research

Given the importance of metals in biology and in the development of modern chemotherapeutic agents, the major research interest of Dr. Guo’s lab focuses on the chemical biology of metals and metallodrugs. In the last two decades or so, he has been working on the design and application of fluorescent sensors for biological metals such as zinc, copper and iron, etc. Visible light excitable and ratiometric metal sensors have been constructed based on a number of design strategies. Localization and intracellular distribution of metal species can be tracked using sensors of different emission wavelengths in combination with fluorescent microscopic techniques. He has also been focusing on the understanding of mechanism of action of platinum anticancer drugs and the development of anti-tumor active metal complexes with novel structural features. Multi-nuclear platinum(II) complexes with novel DNA binding ability, platinum(II)/(IV) complexes with tissue and organelle-targeting abilities have been designed. Approaches towards the targeted delivery of clinically-used anticancer platinum drugs have been adopted including the use of native ferritin, superparamagnetic iron nanoparticles, and stimuli-responsive biodegradable nanomaterials.

Biography

Zijian Guo was born in Hebei, China in 1961. He received his PhD degree from the University of Padova and worked as a postdoctoral research fellow at Birkbeck College, the University of London. He worked also as a research associate at the University of Edinburgh. He joined the School of Chemistry and Chemical Engineering at Nanjing University as a professor of chemistry in 1999, where he served as the director of the State Key Laboratory of Coordination Chemistry from 2000 to 2009 and the dean of the School of Chemistry and Chemical Engineering from 2006 to 2014. He received the national science fund for distinguished young scholars in 1999. He is the Changjiang professor in the same school. He founded Chemistry and Biomedicine Innovation Center (ChemBIC) in Nanjing University in 2019, and is serving as the director of ChemBIC since then. He was elected to the fellow of the Chinese Academy of Sciences in 2017. He served as an associated Editor for Coord. Chem. Rev. He has authored or co-authored more than 400 peer-reviewed articles on basic and applied research topics, with a primary focus on fluorescent probes, chemical biology of metals, and metal-based antitumor complexes.

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug